Literature DB >> 26046681

Salivary Immunosuppressive Cytokines IL-10 and IL-13 Are Significantly Elevated in Oral Squamous Cell Carcinoma Patients.

Salman Aziz1, Syed Shoaib Ahmed, Asad Ali, Faiza Akhter Khan, Gulraiz Zulfiqar, Javed Iqbal, Ayyaz Ali Khan, Muhammad Shoaib.   

Abstract

Oral squamous cell carcinoma (OSCC) is considered to be one of the most fatal diseases worldwide, owing to its late diagnosis and lack of availability of established reliable biomarkers. The aim of this study was to highlight the significance of immunosuppressive cytokines as potential biomarkers in OSCC. Whole unstimulated saliva was collected from each individual (30 OSCC patients and 33 age- and gender-matched healthy controls). Immunosuppressive cytokines, including IL-4, IL-10, IL-13, and IL-1RA, were evaluated in each sample using Luminex multianalyte profiling (xMAP) technology on BioPlex instrument. Our results showed that all the studied salivary cytokines were raised in OSCC patients as compared to controls, where IL-10 and IL-13 salivary levels showed statistically significant difference (p = .004 and p = .010, respectively). Mean levels of salivary cytokines in three histologically defined OSCC categories, compared employing one-way ANOVA, showed that salivary levels of IL-1RA were highest in patients having poorly differentiated OSCC tumors as compared to those having moderately and well-differentiated tumors (p = .000 and p = .002, respectively). Among OSCC individuals, duration of smokeless tobacco correlated positively with IL-1RA (p = .036). We conclude that salivary levels of immunosuppressive cytokines, IL-4, IL-10, IL-13, and IL-1RA, could prove to be potential biomarkers of OSCC and can be further investigated as markers of early detection and disease progression.

Entities:  

Keywords:  5-Parameter logistic; SEM; Cytokine expression profiling; CTL; Cytokines; Cytotoxic T lymphocyte; Interleukin-1 receptor antagonist; Interleukin-10; Interleukin-13; Interleukin-4; Interleukin; RT; Multianalyte profiling; CEP; OSCC; Oral squamous cell carcinoma; TH1; Phycoerythrin; 5-PL; Room temperature; PE; Salivary proteins; Squamous cell carcinoma of head and neck; Standard deviation; xMAP; Standard error of mean; SD; T helper 1 lymphocytes; TH2; T helper 2 lymphocytes; IL

Mesh:

Substances:

Year:  2015        PMID: 26046681     DOI: 10.3109/07357907.2015.1041642

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  25 in total

Review 1.  Clinical validity of saliva and novel technology for cancer detection.

Authors:  Karolina Elżbieta Kaczor-Urbanowicz; Fang Wei; Shannon Liu Rao; Jinseok Kim; Heebum Shin; Jordan Cheng; Michael Tu; David T W Wong; Yong Kim
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-05-30       Impact factor: 10.680

2.  Oral sampling methods are associated with differences in immune marker concentrations.

Authors:  Carole Fakhry; Fares Qeadan; Robert H Gilman; Pablo Yori; Margaret Kosek; Nicole Patterson; David W Eisele; Christine G Gourin; Chandala Chitguppi; Morgan Marks; Patti Gravitt
Journal:  Laryngoscope       Date:  2017-11-24       Impact factor: 3.325

3.  Cell genomics and immunosuppressive biomarker expression influence PD-L1 immunotherapy treatment responses in HNSCC-a computational study.

Authors:  Amber M Bates; Emily A Lanzel; Fang Qian; Taher Abbasi; Shireen Vali; Kim A Brogden
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2017-05-25

4.  HDAC6 is a prognostic biomarker that mediates IL-13 expression to regulate macrophage polarization through AP-1 in oral squamous cell carcinoma.

Authors:  Chung-Chih Tseng; Tsung-Hua Hsieh; Shi-Ying Huang; Hung-Pei Tsai; Chia-Wei Wu
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

5.  Immuno-reactive cancer organoid model to assess effects of the microbiome on cancer immunotherapy.

Authors:  Ethan Shelkey; David Oommen; Elizabeth R Stirling; David R Soto-Pantoja; Katherine L Cook; Yong Lu; Konstantinos I Votanopoulos; Shay Soker
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

6.  Association between interleukin-10 gene polymorphisms and risk of oral carcinoma: A meta-analysis.

Authors:  Fan Li; Xing Xu; Chao Xuan; Wan-Tao Chen
Journal:  Histol Histopathol       Date:  2020-10-29       Impact factor: 2.303

Review 7.  Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment.

Authors:  Sabah Nisar; Parvaiz Yousuf; Tariq Masoodi; Nissar A Wani; Sheema Hashem; Mayank Singh; Geetanjali Sageena; Deepika Mishra; Rakesh Kumar; Mohammad Haris; Ajaz A Bhat; Muzafar A Macha
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

8.  Analysis of oral yeast microflora in patients with oral squamous cell carcinoma.

Authors:  Attila Gácser; Katalin Nagy; Csaba Berkovits; Adél Tóth; Judit Szenzenstein; Tünde Deák; Edit Urbán
Journal:  Springerplus       Date:  2016-08-04

9.  Matrix metalloproteinase (MMP) and immunosuppressive biomarker profiles of seven head and neck squamous cell carcinoma (HNSCC) cell lines.

Authors:  Amber M Bates; Maria Paula Gomez Hernandez; Emily A Lanzel; Fang Qian; Kim A Brogden
Journal:  Transl Cancer Res       Date:  2018-06       Impact factor: 1.241

Review 10.  Salivary Cytokines as Biomarkers for Oral Squamous Cell Carcinoma: A Systematic Review.

Authors:  Elena Ferrari; Margherita E Pezzi; Diana Cassi; Thelma A Pertinhez; Alberto Spisni; Marco Meleti
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.